Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Resmed (RSMDF) Finished Goods (2016 - 2025)

Historic Finished Goods for Resmed (RSMDF) over the last 16 years, with Q4 2025 value amounting to $546.3 million.

  • Resmed's Finished Goods rose 614.35% to $546.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $546.3 million, marking a year-over-year increase of 614.35%. This contributed to the annual value of $557.9 million for FY2025, which is 2024.07% up from last year.
  • Per Resmed's latest filing, its Finished Goods stood at $546.3 million for Q4 2025, which was up 614.35% from $580.5 million recorded in Q3 2025.
  • Resmed's 5-year Finished Goods high stood at $580.5 million for Q3 2025, and its period low was $265.6 million during Q4 2021.
  • Over the past 5 years, Resmed's median Finished Goods value was $489.3 million (recorded in 2024), while the average stood at $453.7 million.
  • Its Finished Goods has fluctuated over the past 5 years, first soared by 9676.22% in 2022, then plummeted by 2188.63% in 2024.
  • Over the past 5 years, Resmed's Finished Goods (Quarter) stood at $265.6 million in 2021, then skyrocketed by 96.76% to $522.5 million in 2022, then dropped by 11.38% to $463.0 million in 2023, then rose by 11.16% to $514.7 million in 2024, then rose by 6.14% to $546.3 million in 2025.
  • Its last three reported values are $546.3 million in Q4 2025, $580.5 million for Q3 2025, and $557.9 million during Q2 2025.